PCG announces deal with Japanese medical publisher

Share this on social media:

Sales, marketing and research consultancy Publishers Communication Group (PCG), a division of Publishing Technology, has signed a sales representation deal with leading Japanese medical publisher, Meteo, to help expand the reach of its Medical Online-E information service into North and South America.

Hosting around 800 medical journals, over 1.3 million articles as well as references and abstracts, Medical Online-E is designed to deliver Japanese medical content and expertise to English speaking audiences around the world. The site aggregates content in English from a diverse range of medical fields, including general medicine, clinical surgery, dentistry, medical technology, nursing, nutrition, pharmaceutical sciences, public health, and many more.

As the sole vendor for Medical Online-E in North and South America, PCG will execute sales and marketing programs, selling subscriptions to academic institutions and medical institutions across the region.

Yuji Tahara, president of Meteo, said: 'We launched our Medical Online-E service in 2008 and its original edition, Medical Online which started in 2001, now serves over 800,000 end users in Japan alone. Last year we developed a multi-language translation tool which is now built into the site so that medical professionals, stakeholders and researchers around the globe can enjoy access to our content.

'We are delighted to be working with PCG on spreading the word about Medical Online-E and look forward to welcoming new worldwide audiences to the platform as a result of its efforts.'

Melissanne Scheld, managing director of PCG, added: 'We are very excited to have signed this deal with Meteo to help sell and market its Medical Online-E platform in the Americas. The site is incredibly rich and broad in scope, containing the most valuable medical content from across the medical communities in Japan, which make it a powerful resource for Western institutions. We are convinced that our proficiency and connections in the medical arena will help a great deal in extending the global appeal of this product.'